259 related articles for article (PubMed ID: 29509792)
1. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era.
Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Synergy Testing of Gentamicin, an Old Drug Suggested as Future Treatment Option for Gonorrhoea, in Combination With Six Other Antimicrobials Against Multidrug-Resistant Neisseria gonorrhoeae Strains.
Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
Sex Transm Dis; 2018 Feb; 45(2):127-131. PubMed ID: 28876284
[TBL] [Abstract][Full Text] [Related]
3.
Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
[TBL] [Abstract][Full Text] [Related]
4. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.
Wind CM; de Vries HJ; van Dam AP
Int J Antimicrob Agents; 2015 Mar; 45(3):305-8. PubMed ID: 25532741
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy for gonorrhoea: in vitro synergy testing.
Pereira R; Cole MJ; Ison CA
J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of gentamicin and azithromycin-based combination therapy against Neisseria gonorrhoeae isolates in India.
Sood S; Agarwal SK; Singh R; Gupta S; Sharma VK
J Med Microbiol; 2019 Apr; 68(4):555-559. PubMed ID: 30869583
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae.
Furuya R; Koga Y; Irie S; Ikeda F; Kanayama A; Kobayashi I; Tanaka M
J Infect Chemother; 2013 Dec; 19(6):1218-20. PubMed ID: 23564350
[TBL] [Abstract][Full Text] [Related]
8. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.
Barbee LA; Soge OO; Holmes KK; Golden MR
J Antimicrob Chemother; 2014 Jun; 69(6):1572-8. PubMed ID: 24468865
[TBL] [Abstract][Full Text] [Related]
9. In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae.
Bharat A; Martin I; Zhanel GG; Mulvey MR
J Infect Chemother; 2016 Mar; 22(3):194-7. PubMed ID: 26603424
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of tigecycline alone and antimicrobial combinations against clinical Neisseria gonorrhoeae isolates.
Lee H; Kim H; Seo YH; Yong D; Jeong SH; Lee K; Chong Y
Diagn Microbiol Infect Dis; 2017 Feb; 87(2):160-162. PubMed ID: 27890419
[TBL] [Abstract][Full Text] [Related]
11. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
[TBL] [Abstract][Full Text] [Related]
13. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
Lewis DA
Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
[TBL] [Abstract][Full Text] [Related]
14. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
Allen GP; Deao KM; Hill SA; Schipelliti SM; Tran T
Int J Antimicrob Agents; 2021 Oct; 58(4):106417. PubMed ID: 34391903
[TBL] [Abstract][Full Text] [Related]
16. Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012.
Bala M; Singh V; Bhargava A; Ramesh V
Sex Transm Dis; 2015 Apr; 42(4):218-22. PubMed ID: 25763675
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains.
Jacobsson S; Golparian D; Phan LT; Ohnishi M; Fredlund H; Or YS; Unemo M
J Antimicrob Chemother; 2015 Jan; 70(1):173-7. PubMed ID: 25182063
[TBL] [Abstract][Full Text] [Related]
18. Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
Brunner A; Nemes-Nikodem E; Jeney C; Szabo D; Marschalko M; Karpati S; Ostorhazi E
Ann Clin Microbiol Antimicrob; 2016 Sep; 15(1):53. PubMed ID: 27646968
[TBL] [Abstract][Full Text] [Related]
19. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
[TBL] [Abstract][Full Text] [Related]
20. Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?
Martins JM; Scheffer MC; de Melo Machado H; Schörner MA; Golfetto L; Santos TMD; Barazzetti FH; de Albuquerque VCB; Bazzo ML
J Microbiol Methods; 2022 Jun; 197():106480. PubMed ID: 35526670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
